# FDA Warning Letter: ImmunityBio, Inc.
> 2026-03-24 · The Office of Prescription Drug Promotion (OPDP) · `362882de23e0f7ba`
## Letter
- **Company:** ImmunityBio, Inc.
- **Posted Date:** 2026-03-24
- **Letter Issue Date:** 2026-03-13
- **Issuing Office:** The Office of Prescription Drug Promotion (OPDP)
## Subject
False & Misleading Claims/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*